Oslo - Delayed Quote NOK

Hofseth BioCare ASA (HBC.OL)

Compare
2.3500
-0.1400
(-5.62%)
At close: 4:25:04 PM GMT+2
Loading Chart for HBC.OL
  • Previous Close 2.4900
  • Open 2.4900
  • Bid 2.2500 x 800000
  • Ask 2.3500 x 619400
  • Day's Range 2.2500 - 2.4900
  • 52 Week Range 1.1600 - 3.6000
  • Volume 72,375
  • Avg. Volume 130,330
  • Market Cap (intraday) 966.029M
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

www.hofsethbiocare.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HBC.OL

View More

Performance Overview: HBC.OL

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .

YTD Return

HBC.OL
38.24%
OBX Total Return Index (OBX.OL)
4.99%

1-Year Return

HBC.OL
17.50%
OBX Total Return Index (OBX.OL)
11.20%

3-Year Return

HBC.OL
53.00%
OBX Total Return Index (OBX.OL)
20.90%

5-Year Return

HBC.OL
66.79%
OBX Total Return Index (OBX.OL)
112.80%

Compare To: HBC.OL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HBC.OL

View More

Valuation Measures

As of 4/2/2025
  • Market Cap

    1.02B

  • Enterprise Value

    1.17B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.98

  • Price/Book (mrq)

    16.51

  • Enterprise Value/Revenue

    4.54

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -46.47%

  • Return on Assets (ttm)

    -17.96%

  • Return on Equity (ttm)

    -240.93%

  • Revenue (ttm)

    265.54M

  • Net Income Avi to Common (ttm)

    -123.41M

  • Diluted EPS (ttm)

    -0.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.58M

  • Total Debt/Equity (mrq)

    278.74%

  • Levered Free Cash Flow (ttm)

    21.85M

Research Analysis: HBC.OL

View More

People Also Watch